Evidence map›Paper›PMID 30192635›Full record

ArticleAmerican journal of respiratory and critical care medicine2019

Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.

Andrew W Norris

Open access · greenAbstract readEditorialComment
In one paragraph

Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Update in Cystic Fibrosis 2018.American journal of respiratory and critical care medicine · 2019
    Review
  6. Inhaled Biologicals for the Treatment of Cystic Fibrosis.Recent patents on inflammation & allergy drug discovery · 2019
    Review
  7. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Andrew W Norris1 Fraternal Order of Eagles Diabetes Research Center University of Iowa Iowa City, Iowa.
University of Iowa · US

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Early Pathogenesis of Cystic Fibrosis Related DiabetesR24DK096518 · NIDDK · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F, MORAN, ANTOINETTE M. · 2012 to 2018
$10.1M
Splanchno-Hormonal Mechanisms of Cystic Fibrosis Related DiabetesR01DK115791 · NIDDK · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F, NORRIS, ANDREW W · 2018 to 2021
$1.9M
NIDDK NIH HHS P30 DK054759NIDDK NIH HHS R01 DK115791NIDDK NIH HHS R24 DK096518
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisDiabetes MellitusAminophenolsCystic Fibrosis Transmembrane Conductance RegulatorHumansIncretinsInsulin SecretionQuinolonesAminophenolsCystic Fibrosis Transmembrane Conductance RegulatorIncretinsivacaftorQuinolones

Identifiers

PMID30192635
PMCPMC6363979
OpenAlexW2889812554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.